Insider · CIK 0001619834

Burke Steven Keith

Reports to the SEC for 3 companies · JERSEY CITY, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001619834

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-18	SCYXSCYNEXIS INCA Award	Director	AAward	+5,750 sh	—	—	5,750
2026-09-18	SCYXSCYNEXIS INC · Stock Option (Right to Buy)A Award	Director	AAward	+5,750 sh	—	—	5,750
2026-02-02	AKBAAkebia Therapeutics, Inc.S Sale	SVP, Chief Medical Officer	SSale	−21.6K sh	$1.39	−$30K	994,508
2026-02-02	AKBAAkebia Therapeutics, Inc.S Sale	SVP, Chief Medical Officer	SSale	−20.7K sh	$1.39	−$28.8K	948,432
2026-02-02	AKBAAkebia Therapeutics, Inc.S Sale	SVP, Chief Medical Officer	SSale	−25.4K sh	$1.39	−$35.3K	969,133
2026-01-30	AKBAAkebia Therapeutics, Inc.A Award	SVP, Chief Medical Officer	AAward	+204K sh	—	—	1,016,090
2026-01-30	AKBAAkebia Therapeutics, Inc. · Stock Option (Right to buy)A Award	SVP, Chief Medical Officer	AAward	+320K sh	—	—	320,000
2025-03-03	AKBAAkebia Therapeutics, Inc.S Sale	SVP, Chief Medical Officer	SSale	−7,144 sh	$1.83	−$13.1K	809,090
2025-02-03	AKBAAkebia Therapeutics, Inc.S Sale	SVP, Chief Medical Officer	SSale	−27.2K sh	$2.10	−$57.2K	816,234
2025-02-03	AKBAAkebia Therapeutics, Inc.S Sale	SVP, Chief Medical Officer	SSale	−23.3K sh	$2.10	−$48.9K	843,470
2025-01-31	AKBAAkebia Therapeutics, Inc.A Award	SVP, Chief Medical Officer	AAward	+195K sh	—	—	866,740
2025-01-31	AKBAAkebia Therapeutics, Inc. · Stock Option (Right to buy)A Award	SVP, Chief Medical Officer	AAward	+292K sh	—	—	292,300
2024-02-29	AKBAAkebia Therapeutics, Inc.S Sale	SVP, Chief Medical Officer	SSale	−7,169 sh	$1.58	−$11.3K	695,840
2024-02-27	AKBAAkebia Therapeutics, Inc.S Sale	SVP, Chief Medical Officer	SSale	−8,367 sh	$1.52	−$12.7K	703,009
2024-02-01	AKBAAkebia Therapeutics, Inc.S Sale	SVP, Chief Medical Officer	SSale	−24.3K sh	$1.68	−$40.8K	711,376
2024-01-31	AKBAAkebia Therapeutics, Inc. · Stock Option (Right to buy)A Award	SVP, Chief Medical Officer	AAward	+303K sh	—	—	303,300
2024-01-31	AKBAAkebia Therapeutics, Inc.A Award	SVP, Chief Medical Officer	AAward	+202K sh	—	—	735,687
2023-08-25	AKBAAkebia Therapeutics, Inc.S Sale	SVP, Chief Medical Officer	SSale	−27K sh	$1.15	−$31K	668,840
2023-05-16	AKBAAkebia Therapeutics, Inc.S Sale	SVP, Chief Medical Officer	SSale	−63.6K sh	$1.07	−$67.9K	530,487
2023-03-01	AKBAAkebia Therapeutics, Inc.S Sale	SVP, Chief Medical Officer	SSale	−1,110 sh	$0.88	−$974.025	594,054
2023-03-01	AKBAAkebia Therapeutics, Inc.S Sale	SVP, Chief Medical Officer	SSale	−6,400 sh	$0.88	−$5,616	595,164
2023-03-01	AKBAAkebia Therapeutics, Inc.S Sale	SVP, Chief Medical Officer	SSale	−6,613 sh	$0.88	−$5,802.907	601,564
2023-02-27	AKBAAkebia Therapeutics, Inc.S Sale	SVP, Chief Medical Officer	SSale	−7,539 sh	$0.81	−$6,130.715	608,177
2023-01-31	AKBAAkebia Therapeutics, Inc. · Stock Option (Right to buy)A Award	SVP, Chief Medical Officer	AAward	+294K sh	—	—	294,300
2023-01-31	AKBAAkebia Therapeutics, Inc.A Award	SVP, Chief Medical Officer	AAward	+196K sh	—	—	615,716
2022-08-31	AKBAAkebia Therapeutics, Inc.S Sale	SVP, Chief Medical Officer	SSale	−1,147 sh	$0.36	−$415.787	418,016
2022-05-12	AKBAAkebia Therapeutics, Inc.A Award	SVP, Chief Medical Officer	AAward	+200K sh	—	—	417,663
2022-05-12	AKBAAkebia Therapeutics, Inc. · Stock Option (Right to buy)A Award	SVP, Chief Medical Officer	AAward	+200K sh	—	—	200,000
2022-03-01	AKBAAkebia Therapeutics, Inc.S Sale	SVP, Chief Medical Officer	SSale	−6,556 sh	$2.17	−$14.2K	217,263
2022-03-01	AKBAAkebia Therapeutics, Inc.S Sale	SVP, Chief Medical Officer	SSale	−1,100 sh	$2.17	−$2,387.77	217,663
2022-02-28	AKBAAkebia Therapeutics, Inc.S Sale	SVP, Chief Medical Officer	SSale	−7,400 sh	$2.15	−$15.9K	163,819
2022-02-28	AKBAAkebia Therapeutics, Inc. · Employee Stock Option (Right to buy)A Award	SVP, Chief Medical Officer	AAward	+225K sh	—	—	225,000
2022-02-28	AKBAAkebia Therapeutics, Inc.A Award	SVP, Chief Medical Officer	AAward	+60K sh	—	—	223,819
2021-08-31	AKBAAkebia Therapeutics, Inc.S Sale	SVP, Chief Medical Officer	SSale	−1,042 sh	$2.83	−$2,948.86	171,219
2021-04-01	AKBAAkebia Therapeutics, Inc.S Sale	SVP, Chief Medical Officer	SSale	−1,081 sh	$3.40	−$3,675.4	170,761
2021-03-16	AKBAAkebia Therapeutics, Inc.A Award	SVP, Chief Medical Officer	AAward	+10.4K sh	—	—	171,842
2021-03-01	AKBAAkebia Therapeutics, Inc.S Sale	SVP, Chief Medical Officer	SSale	−7,558 sh	$3.40	−$25.7K	161,442
2021-02-26	AKBAAkebia Therapeutics, Inc.A Award	SVP, Chief Medical Officer	AAward	+70K sh	—	—	169,000
2021-02-26	AKBAAkebia Therapeutics, Inc. · Employee Stock Option (Right to buy)A Award	SVP, Chief Medical Officer	AAward	+120K sh	—	—	120,000
2020-02-28	AKBAAkebia Therapeutics, Inc.A Award	SVP, Chief Medical Officer	AAward	+62K sh	—	—	99,000
2020-02-28	AKBAAkebia Therapeutics, Inc. · Stock Option (Right to buy)A Award	SVP, Chief Medical Officer	AAward	+106K sh	—	—	105,500
2019-11-20	AKBAAkebia Therapeutics, Inc.P Purchase	SVP, Chief Medical Officer	PPurchase	+27K sh	$3.58	+$96.7K	37,000
2019-08-30	AKBAAkebia Therapeutics, Inc. · Employee Stock Option (Right to buy)A Award	SVP, Chief Medical Officer	AAward	+250K sh	—	—	250,000
2019-08-30	AKBAAkebia Therapeutics, Inc.A Award	SVP, Chief Medical Officer	AAward	+10K sh	—	—	10,000
2019-03-15	TARAProtara Therapeutics, Inc.G Gift	SVP and Chief Medical Officer	GGift	−7,333 sh	—	—	109,251
2019-03-15	TARAProtara Therapeutics, Inc.G Gift	SVP and Chief Medical Officer	GGift	+7,333 sh	—	—	18,999
2019-03-15	TARAProtara Therapeutics, Inc.G Gift	SVP and Chief Medical Officer	GGift	+7,333 sh	—	—	26,332
2019-03-15	TARAProtara Therapeutics, Inc.G Gift	SVP and Chief Medical Officer	GGift	−7,334 sh	—	—	116,584
2019-03-15	TARAProtara Therapeutics, Inc.G Gift	SVP and Chief Medical Officer	GGift	−7,333 sh	—	—	101,917
2019-01-18	TARAProtara Therapeutics, Inc. · Stock Option (Right to Buy)A Award	SVP and Chief Medical Officer	AAward	+145K sh	—	—	145,000

Recent filings

Accepted (ET)
Sep 224
Burke Steven Keith0001193125-26-397873
SEC(opens sec.gov)
Feb 44
Burke Steven Keith0001619834-26-000002
SEC(opens sec.gov)
Feb 34
Burke Steven Keith0001619834-26-000001
SEC(opens sec.gov)
Mar 44
Burke Steven Keith0001562180-25-001997
SEC(opens sec.gov)
Feb 44
Burke Steven Keith0001562180-25-000916
SEC(opens sec.gov)
May 94
Burke Steven Keith0001562180-24-003948
SEC(opens sec.gov)
Mar 14
Burke Steven Keith0001562180-24-002020
SEC(opens sec.gov)
Feb 294
Burke Steven Keith0001562180-24-001993
SEC(opens sec.gov)
Feb 24
Burke Steven Keith0001562180-24-000970
SEC(opens sec.gov)
May 184
Burke Steven Keith0001562180-23-004254
SEC(opens sec.gov)
Mar 34
Burke Steven Keith0001562180-23-002199
SEC(opens sec.gov)

Companies

Address

1 EVERTRUST PLAZA 13TH FLOOR

JERSEY CITY, NJ, 07302